These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34181821)

  • 1. Prevalence of function-limiting late effects in Hodgkin lymphoma survivors.
    Enam N; Chou K; Stubblefield MD
    PM R; 2022 Jul; 14(7):811-817. PubMed ID: 34181821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.
    Lammers EMJ; Zijlstra JM; Retèl VP; Aleman BMP; van Leeuwen FE; Nijdam A;
    JMIR Res Protoc; 2024 Apr; 13():e55601. PubMed ID: 38635308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
    Matasar MJ; Ford JS; Riedel ER; Salz T; Oeffinger KC; Straus DJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25717170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.
    Daniëls LA; Oerlemans S; Krol AD; van de Poll-Franse LV; Creutzberg CL
    Ann Hematol; 2013 Aug; 92(8):1023-32. PubMed ID: 23728609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
    Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
    BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Perceived Risk at Which Clinician and Patient Stakeholders Initiate Activities to Prevent Late Effects Among Breast Cancer Survivors.
    Alvarado I; Wisotzky E; Cheville AL
    Arch Rehabil Res Clin Transl; 2019 Jun; 1(1-2):100006. PubMed ID: 33543046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma.
    Agrusa JE; Kothari VD; Brown AL; Masand PM; Lewis GD; Teh BS; Paulino AC; Silva-Carmona MD; Melicoff E; Allen CE; Gramatges MM
    Leuk Lymphoma; 2020 Oct; 61(10):2419-2427. PubMed ID: 32519904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study.
    Khimani N; Chen YH; Mauch PM; Recklitis C; Diller L; Silver B; Ng AK
    Ann Oncol; 2013 Jan; 24(1):226-30. PubMed ID: 22875834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CE: Caring for Survivors of Hodgkin Lymphoma.
    Lin X; Corcoran S
    Am J Nurs; 2019 Feb; 119(2):32-41. PubMed ID: 30640208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees.
    Ehrhardt MJ; Flerlage JE; Armenian SH; Castellino SM; Hodgson DC; Hudson MM
    J Natl Compr Canc Netw; 2021 Jun; 19(6):755-764. PubMed ID: 34214967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis.
    Lo AC; Chen B; Samuel V; Savage KJ; Freeman C; Goddard K
    J Cancer Surviv; 2021 Dec; 15(6):837-846. PubMed ID: 33453004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer rehabilitation.
    Stubblefield MD
    Semin Oncol; 2011 Jun; 38(3):386-93. PubMed ID: 21600368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late effects of treatment for Hodgkin lymphoma.
    Friedman DL; Constine LS
    J Natl Compr Canc Netw; 2006 Mar; 4(3):249-57. PubMed ID: 16507272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany.
    Gebauer J; Fick EM; Waldmann A; Langer T; Kreitschmann-Andermahr I; Lehnert H; Katalinic A; Brabant G
    Eur J Endocrinol; 2015 Aug; 173(2):139-48. PubMed ID: 25947143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.